Cite
HARVARD Citation
Coquan, E. et al. (n.d.). 2022-RA-579-ESGO A phase II study assessing safety and efficacy of cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure (CABOCOL study). International journal of gynecological cancer. p. A14. [Online].